Invesco Pharmaceuticals ETF
PJP
PJP
81 hedge funds and large institutions have $64.5M invested in Invesco Pharmaceuticals ETF in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 22 increasing their positions, 26 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
71% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 17
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
81
Holding in Top 10
–
Calls
–
Puts
$1K
Top Buyers
1 | +$2.09M | |
2 | +$477K | |
3 | +$209K | |
4 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$192K |
5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$192K |
Top Sellers
1 | -$7.41M | |
2 | -$2.14M | |
3 | -$1.37M | |
4 |
Citadel Advisors
Miami,
Florida
|
-$950K |
5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$654K |